Based on GuruFocus estimates, the estimated GF Value for Apellis Pharmaceuticals Inc (NASDAQ:APLS) in one year is $220.19, suggesting an upside of 736.27% from the current price of $26.33.

For the quarter ended December 2024, Apellis Pharmaceuticals, Inc. (APLS) reported revenue of $212.53 million, up 45.2% over the same period last year. EPS came in at -$0.29, compared to -$0.73 in ...

Short interest in Apellis Pharmaceuticals Inc (NASDAQ:APLS) increased during the last reporting period, rising from 17.06M to 17.34M. This put 19.09% of the company's publicly available shares short.

APELLIS PHARMACEUTICALS ($APLS) is expected to release its quarterly earnings data on Friday, February 28th before market open, per Finnhub. Analysts are expecting ...